Muhammad Umair Mushtaq

Assistant Professor of Medicine

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Muhammad Umair Mushtaq is an Assistant Professor of Medicine at the University of Kansas Medical Center. His research primarily focuses on multiple myeloma, exploring areas such as CAR-T therapy access disparities, efficacy outcomes, and the social determinants of health. He has published several articles addressing critical issues in hematologic malignancies and health equity related to treatment availability and outcomes.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Muhammad Ameen Rauf

Assistant Professor of Surgery

Vanderbilt University Medical Center

UNITED STATES

View details

Michael Fallon

University of Wisconsin-Madison

UNITED STATES

View details

Peiman Hematti

Professor

Medical College of Wisconsin

UNITED STATES

View details

Peter Riedell

University of Chicago

UNITED STATES

View details

Irfan Saadi

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

Aparna Hegde

The University of Alabama

UNITED STATES

View details

Muhammad Kashif Amin

Clinical Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

Nausheen Ahmed

Assistant Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Muhammad Umair Mushtaq

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

CAR-T Access Disparities for Multiple Myeloma in the Midwest: A Social Determinants of Health Perspective

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World Experience

Global Access to Multiple Myeloma Therapies

Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma

BCMA-Directed MRD Detection as a Predictor of Relapse after BCMA CAR T in Multiple Myeloma

The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation

Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma

Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy

Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis

"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy

Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis

Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection

Functional characterization of NPM1–TYK2 fusion oncogene

Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review

Impact of COVID-19 in Hematopoietic stem cell transplant recipients: A systematic review and meta-analysis

Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia

Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients

Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Collaborators (8)

Muhammad Ameen Rauf

Michael Fallon

Peiman Hematti

Peter Riedell

Irfan Saadi

Aparna Hegde

Muhammad Kashif Amin

Nausheen Ahmed

Make your next move.